Falling behind: The US has been slow to integrate new biosimilars for treating RA

Interpreting DAS28-CRP: A marker for clinical improvement in RA?

The unlikely link between the Black Death and RA

Beyond the joints: Unraveling the psychological effects of arthritis

Ankylosing spondylitis and RA: Possible comorbidities?

Many RA patients are resistant to DMARD therapy. Here's how to address this obstacle head-on

Invisible symptom: The heavy toll of fatigue in inflammatory arthritis

Expert advice: Top reasons why RA patients quit their treatment plan

My battle with RA: Managing communication challenges with my care team

Sex-based differences in the presentation of PsA

Adopt a treat-to-target approach to psoriatic arthritis

Resources for physicians who treat psoriatic arthritis

Psoriatic arthritis and diet: Can nutrition provide relief?

Doctor's reflections: Lessons learned from treating psoriatic arthritis in a young patient

Spotlight on axSpA: 3 influential studies on the radar

Disease activity measures to improve outcomes in axSpA

Why multidisciplinary teams are crucial in treating nr-AxSpA

Practice essentials: Addressing the progression of axial spondyloarthritis

Biologics can be scary for patients: Addressing your patient’s fears

Addressing the challenges of a shrinking rheumatology workforce

Wearable activity trackers show promise in rheumatic disease

What can precision medicine do for rheumatology?

Breakthroughs in rheumatology: These drugs show the most promise in RA treatment

‘Omics’ are at the forefront of rheumatic disease treatment